Explore the vast range of titles available.

This study evaluates the prevalence of epilepsy within the Saudi population. A comprehensive computerized search of pertinent databases was carried out to find research that satisfied the requirements for inclusion. The search encompassed PubMed, SCOPUS, Science Direct, Cochrane Library, and Web of Science to find pertinent research. Our analysis included six studies with a total of 7408 Saudi participants. Females comprised the majority of the participants, totaling 6663 (89.9%). The prevalence of epilepsy among Saudi adults is underreported. Structural causes, such as cerebrovascular events and malignancies, were the most frequent etiologies, followed by genetic factors. A notable proportion of cases had an unknown cause. Gender-specific patterns were observed to show increased seizure severity in males whilst females showed age-specific vulnerability. This review emphasizes the complexity of epileptic conditions within the Saudi population, with diverse causes ranging from structural and genetic factors to strokes and head trauma. While males were more likely to experience severe seizures, females faced age-related vulnerability, pointing to the need for gender-sensitive treatment strategies. The lack of clear causes in nearly half of the cases further emphasizes the need for improved diagnostic approaches. However, the significant gap in prevalence studies within Saudi Arabia limits our understanding of the true burden of epilepsy in the region. Moving forward, comprehensive epidemiological studies focusing on prevalence and risk factors are crucial to inform public health strategies and improve outcomes for individuals living with epilepsy in Saudi Arabia.

This study aims to conduct a thorough analysis of the existing studies to determine how patients with acute cholecystitis (AC) respond to surgical intervention at different times following their diagnosis. To locate studies that met the inclusion criteria, a thorough computerized search of relevant databases was carried out. A comprehensive search was carried out on PubMed, SCOPUS, Science Direct, Cochrane Library, and Web of Science to locate relevant material. Our data included seven trials with 48,747 patients: 40,955 in the early laparoscopic cholecystectomy (ELC) group and 7,792 in the delayed laparoscopic cholecystectomy (DLC) group. More than half of the participants (27,687, 56.8%) were female. ELC was found to be safe regardless of when symptoms first appeared, challenging previous assumptions that surgery should be delayed during the initial symptomatic period. Mortality rates for ELC were consistently low, ranging from 0% to 3.9% in all groups, while complication rates varied from 3.5% to 12.5% in all groups as well. Although DLC is still considered safe, the likelihood of complications such as bile duct damage and surgical site infections appeared to increase, particularly in patients who underwent surgery more than three days after the diagnosis of cholecystitis. It is important to note that ELC refers to surgery performed within the first three days after diagnosis, while DLC refers to surgery performed after three days. The systematic review reveals that ELC is a secure and successful remedy for sudden cholecystitis, offering superior outcomes compared to DLC. ELC is associated with lower complication rates, reduced hospital stays, and minimal mortality, suggesting it should be the preferred approach in most cases (performing the surgery within the first three days following the diagnosis of AC). While DLC remains a viable option, particularly for certain patient populations, it carries a higher risk of complications and prolonged recovery times.